Nifty

:

14238.90

Sensex

:

48347.59

-133.00 (-0.93%)
-530.95 (-1.09%)

Login

Nifty
Sensex

:
:

14238.90
48347.59

-133.00 (-0.93%)
-530.95 (-1.09%)

Biofil Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

70/99

BSE: 524396 | NSE: BIOFILCHEM

Watchlist

NSE BSE

119.90

25-Jan-2021

Open
High
Low
Previous Close

119.90
119.90
119.90
126.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

10738
12.87
356.10
6.45

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

193.98
140.57
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

194.92
N/A
12.11

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

30.02
17.65
33.93

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
15.91
14.13

PAT CAGR (%)

10 Years
5 Years
3 Years

2.03
9.18
37.06

P:E (Median)

8 Years
5 Years
3 Years

17.36
18.18
21.13

P:BV (Average)

8 Years
5 Years
3 Years

7.05
7.05
7.05

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.28
19.44
24.83

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 16.02 11.63 37.75% 2.30 1.59 44.65% 3.71 2.47 50.20% 12.75 14.29 -10.78%
Expenses 15.11 10.74 40.69% 2.59 1.44 79.86% 3.20 2.19 46.12% 12.49 13.91 -10.21%
EBITDA 0.91 0.89 2.25% -0.29 0.15 - 0.52 0.28 85.71% 0.26 0.39 -33.33%
EBIDTM 5.67% 7.61% -12.78% 9.72% 13.97% 11.36% 2.06% 2.70%
Other Income 0.15 0.03 400.00% 0.64 0.01 6,300.00% 0.04 0.04 0.00% 0.09 0.02 350.00%
Interest 0.02 0.03 -33.33% 0.03 0.04 -25.00% 0.03 0.04 -25.00% 0.03 0.04 -25.00%
Depreciation 0.11 0.10 10.00% 0.10 0.09 11.11% 0.13 0.14 -7.14% 0.10 0.07 42.86%
PBT 0.93 0.79 17.72% 0.22 0.04 450.00% 0.40 0.14 185.71% 0.23 0.29 -20.69%
Tax 0.00 0.00 0 0.00 0.00 0 0.26 0.12 116.67% 0.00 0.00 0
PAT 0.93 0.79 17.72% 0.22 0.04 450.00% 0.15 0.02 650.00% 0.23 0.29 -20.69%
PATM 5.77% 6.79% 9.34% 2.45% 3.96% 0.81% 1.79% 2.05%
EPS 0.57 0.48 18.75% 0.13 0.02 550.00% 0.09 0.01 800.00% 0.14 0.18 -22.22%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 34.78 29.69 23.13 12.36 13.45 13.17 5.86 7.17 6.01 6.27 2.15 Net Sales Growth 16.01% 28.36% 87.14% -8.10% 2.13% 124.74% -18.27% 19.30% -4.15% 191.63% Cost Of Goods Sold 31.14 25.31 19.99 9.77 8.51 10.53 3.85 4.73 3.71 4.89 1.96 Gross Profit 3.64 4.38 3.14 2.59 4.94 2.65 2.01 2.44 2.30 1.38 0.19 GP Margin 10.45% 14.75% 13.58% 20.95% 36.73% 20.12% 34.30% 34.03% 38.27% 22.01% 8.84% Total Expenditure 33.39 27.87 22.11 11.42 10.83 12.30 5.13 6.21 5.00 5.88 3.26 Power & Fuel Cost - 0.49 0.37 0.33 0.44 0.37 0.35 0.28 0.37 0.23 0.08 % Of Sales - 1.65% 1.60% 2.67% 3.27% 2.81% 5.97% 3.91% 6.16% 3.67% 3.72% Employee Cost - 0.86 0.89 0.73 0.53 0.48 0.50 0.41 0.43 0.40 0.18 % Of Sales - 2.90% 3.85% 5.91% 3.94% 3.64% 8.53% 5.72% 7.15% 6.38% 8.37% Manufacturing Exp. - 0.55 0.20 0.14 0.47 0.49 0.19 0.27 0.20 0.13 0.52 % Of Sales - 1.85% 0.86% 1.13% 3.49% 3.72% 3.24% 3.77% 3.33% 2.07% 24.19% General & Admin Exp. - 0.24 0.24 0.39 0.48 0.32 0.16 0.15 0.20 0.18 0.11 % Of Sales - 0.81% 1.04% 3.16% 3.57% 2.43% 2.73% 2.09% 3.33% 2.87% 5.12% Selling & Distn. Exp. - 0.38 0.39 0.04 0.31 0.06 0.00 0.29 0.01 0.00 0.00 % Of Sales - 1.28% 1.69% 0.32% 2.30% 0.46% 0% 4.04% 0.17% 0% 0% Miscellaneous Exp. - 0.03 0.02 0.02 0.09 0.05 0.08 0.07 0.07 0.05 0.00 % Of Sales - 0.10% 0.09% 0.16% 0.67% 0.38% 1.37% 0.98% 1.16% 0.80% 18.60% EBITDA 1.40 1.82 1.02 0.94 2.62 0.87 0.73 0.96 1.01 0.39 -1.11 EBITDA Margin 4.03% 6.13% 4.41% 7.61% 19.48% 6.61% 12.46% 13.39% 16.81% 6.22% -51.63% Other Income 0.92 0.17 0.10 0.10 0.14 0.53 0.46 0.06 0.06 0.04 2.26 Interest 0.11 0.12 0.16 0.15 0.16 0.15 0.21 0.15 0.19 0.08 0.01 Depreciation 0.44 0.41 0.37 0.30 0.28 0.26 0.25 0.22 0.21 0.19 0.15 PBT 1.78 1.46 0.60 0.59 2.31 0.98 0.74 0.65 0.67 0.16 0.99 Tax 0.26 0.26 0.12 0.12 0.52 0.20 0.15 0.13 0.13 0.01 0.00 Tax Rate 14.61% 17.81% 20.00% 20.34% 22.51% 20.41% 20.27% 20.00% 19.40% 6.25% 0.00% PAT 1.53 1.21 0.48 0.47 1.79 0.78 0.59 0.52 0.54 0.15 0.99 PAT before Minority Interest 1.53 1.21 0.48 0.47 1.79 0.78 0.59 0.52 0.54 0.15 0.99 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.40% 4.08% 2.08% 3.80% 13.31% 5.92% 10.07% 7.25% 8.99% 2.39% 46.05% PAT Growth 34.21% 152.08% 2.13% -73.74% 129.49% 32.20% 13.46% -3.70% 260.00% -84.85% EPS 0.94 0.74 0.29 0.29 1.10 0.48 0.36 0.32 0.33 0.09 0.61

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 14.88 13.65 13.17 12.70 10.91 8.41 7.86 7.36 6.84 6.70 Share Capital 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 Total Reserves -1.39 -2.62 -3.11 -3.58 -5.37 -7.86 -8.41 -8.91 -9.44 -9.57 Non-Current Liabilities 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 27.48 10.56 10.99 9.14 13.23 5.34 6.74 6.13 7.27 3.68 Trade Payables 25.92 8.58 9.14 7.10 11.59 2.11 3.64 3.11 4.72 2.34 Other Current Liabilities 0.12 0.23 0.17 0.12 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Borrowings 1.19 1.64 1.56 1.43 1.37 2.98 2.87 2.79 2.49 1.30 Short Term Provisions 0.25 0.12 0.11 0.50 0.26 0.25 0.23 0.23 0.06 0.03 Total Liabilities 42.36 24.21 24.16 21.84 24.14 13.75 14.60 13.49 14.11 10.38 Net Block 10.09 10.29 9.25 9.16 8.98 9.06 9.17 9.17 9.10 8.49 Gross Block 11.45 11.24 9.83 9.45 11.04 10.85 10.68 10.44 10.14 9.32 Accumulated Depreciation 1.36 0.95 0.58 0.29 2.06 1.79 1.51 1.27 1.04 0.84 Non Current Assets 10.09 10.29 9.25 9.16 8.98 9.06 9.17 9.17 9.10 8.49 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 32.27 13.92 14.91 12.68 15.16 4.70 5.43 4.32 5.01 1.89 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1.69 1.19 1.02 0.17 0.10 0.17 0.27 0.32 0.22 0.06 Sundry Debtors 29.71 12.03 12.98 11.46 13.98 3.65 4.10 3.34 4.11 1.50 Cash & Bank 0.26 0.14 0.37 0.31 0.18 0.13 0.18 0.13 0.25 0.09 Other Current Assets 0.62 0.13 0.10 0.15 0.89 0.75 0.87 0.53 0.42 0.24 Short Term Loans & Adv. 0.43 0.44 0.43 0.59 0.89 0.75 0.87 0.53 0.42 0.24 Net Current Assets 4.79 3.36 3.92 3.53 1.93 -0.64 -1.31 -1.81 -2.26 -1.79 Total Assets 42.36 24.21 24.16 21.84 24.14 13.76 14.60 13.49 14.11 10.38

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 1.04 1.26 0.46 0.71 0.14 0.01 0.21 -0.13 -0.21 -1.25 PBT 1.46 0.60 0.59 2.31 0.98 0.74 0.65 0.67 0.15 0.99 Adjustment 0.56 0.53 0.45 0.45 0.42 0.46 0.37 0.40 0.27 0.49 Changes in Working Capital -0.87 0.25 -0.07 -1.84 -0.96 -0.84 -0.52 -1.00 -0.55 -2.73 Cash after chg. in Working capital 1.15 1.37 0.97 0.91 0.44 0.35 0.50 0.07 -0.13 -1.24 Interest Paid 0.00 0.00 0.00 0.00 -0.15 -0.21 -0.15 -0.19 -0.08 -0.01 Tax Paid -0.11 -0.11 -0.50 -0.20 -0.15 -0.13 -0.14 -0.01 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.21 -1.41 -0.38 -0.48 -0.19 -0.17 -0.24 -0.30 -0.82 -1.00 Net Fixed Assets -0.21 -1.41 -0.38 1.59 -0.19 -0.17 -0.24 -0.30 -0.82 -1.00 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.00 0.00 0.00 -2.07 0.00 0.00 0.00 0.00 0.00 0.00 Cash from Financing Activity -0.72 -0.08 -0.02 -0.11 0.10 0.11 0.08 0.31 1.19 1.05 Net Cash Inflow / Outflow 0.12 -0.24 0.06 0.13 0.05 -0.05 0.05 -0.12 0.16 -1.20 Opening Cash & Equivalents 0.14 0.37 0.31 0.18 0.13 0.18 0.13 0.25 0.09 1.29 Closing Cash & Equivalent 0.26 0.14 0.37 0.31 0.18 0.13 0.18 0.13 0.25 0.09

Financial Ratios

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 9.15 8.39 8.09 7.80 4.39 2.85 2.51 2.19 1.85 1.76 ROA 3.63% 1.99% 2.05% 7.81% 4.13% 4.14% 3.68% 3.93% 1.23% 9.61% ROE 8.46% 3.60% 3.64% 18.09% 13.28% 13.47% 13.53% 16.49% 5.12% 462.75% ROCE 10.12% 5.06% 5.13% 21.86% 14.04% 12.97% 12.09% 14.53% 5.05% 33.57% Fixed Asset Turnover 2.62 2.19 1.28 1.31 1.20 0.54 0.68 0.58 0.64 0.24 Receivable days 256.53 197.31 360.94 345.20 244.36 241.46 189.36 226.24 163.34 145.17 Inventory Days 17.72 17.48 17.59 3.56 3.64 13.70 15.17 16.41 8.18 5.46 Payable days 223.28 146.68 239.24 317.92 205.27 204.15 204.37 274.80 220.37 413.46 Cash Conversion Cycle 50.97 68.12 139.29 30.84 42.72 51.02 0.15 -32.15 -48.85 -262.83 Total Debt/Equity 0.08 0.12 0.12 0.11 0.19 0.64 0.70 0.78 0.82 0.45 Interest Cover 12.96 4.70 4.86 15.12 7.46 4.51 5.24 4.50 2.94 109.70

Top Investors:

starline equifin private limited

libra healthcare private limited

ksl and industries limited

hiren vasantlal shah

kishor himmatsinh jhala

gom industries ltd

Annual Reports:

News Update:

Biofil Chem & Pharma - Quarterly Results
11th Nov 2020, 19:02 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback